All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityABBs-Block Trades

argenx sells $1bn of stock


Dutch biotech firm argenx has tapped equity investors for $1bn (€830.3m) to finance research and development.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login